One in 8 men will develop prostate cancer during his lifetime, mostly after age 70. One in 26 will die of it. Prostate cancer is the most frequently diagnosed cancer in American and Canadian men.

No imaging technology has been developed for the effective screening of prostate cancer.

The obstacle to prostate screening technology development is the difficulty of resolving and differentiating calcification and tumor presence in the shallow tissue of the difficult-to-access prostate area. InnerVision's Flash Ultrasound™ is being developed to offer a non-invasive, diagnostic means of early detection.

• The U.S. National Cancer Institute estimates 9 million men have prostate cancer without knowing.
• Less than half of the 56 million men older than 50 in the U.S. are currently being screened for prostate cancer.

Note: Flash Ultrasound™ is an Investigational Device. It is not currently available for sale. Confirmation of safety and effectiveness is yet to be determined.